본문 바로가기
KERD
논문KCI 등재

뇌경색 입원환자대상으로 한약과 Warfarin의 복합 투여시 미치는 Prothrombin Time(INR)의 변화에 대한 후향적 단면연구

A Retrospective Sectional Study about the Effect of the Interaction of Herbal Medicines and Warfarin on Prothrombin Time(INR) in Stroke Patients

1

조회

0

다운로드

3

인용

0

참고문헌

주제분류한의학

초록

Abstract

Objectives : Nowadays the combined use of oriental herbal medicines and western biomedical medicines has been prevalent but controversial. Warfarin has been much reported to interact with some herbal medicines so that it influences prothrombin time(PT) & international normalized ratio(INR). This study was aimed to examine how much warfarin interacts with herbal medicines during treatment of stroke patients.Methods : This was a retrospective case control study of 53 patients whowere treated with concomitant treatment of herbal medicines & warfarin. They were within normal limit in liver function, renal function, hematocrit, hemoglobin, and platelet count at first admission lab. We classified them into 2 classes: study group (taking herbal medicines including Panax ginseng, Angelica sinensis, Zingiber officinale, Salvia miltiorrhiza that were reported to interact with warfarin to impact PT (INR)) and control group (taking other herbal medicines). We followed up PT (INR) at 5-10 days interval with AST, ALT, BUN, creatinine, hematocrit, hemoglobin, and platelet count.Results : AST, BUN, creatinine, hemoglobin, hematocrit, and platelet count were not changed significantly between first and final tests during the admission period. Only ALT decreased significantly in the control group. Neither baseline nor peak PT (INR) was significantly different between the groups. However, only warfarin dose was significantly correlated with PT and INR (r=0.810, r=0.798, p<0.01).Conclusions : It was concluded that PT(INR) was not influenced with herbal medicines and warfarin but by far dependent on warfarin dose in stroke patients restricted with normal liver function, renal function, and hematocrit, hemoglobin, and platelet count. Further prospective study is needed on larger samples to conclude that the combined therapy of herbal medicines and warfarin is safe.

참고문헌 (26)

  1. "약물상호작용: 현대약과 한약", pp.1~10 (1996), 裕盛出版社
  2. "Herb-Drug interaction:Review and assessment of report reliability", 52, pp.587~595 (2001)
  3. "Possible interactions between synthetic and herbal medicinal products. Part 1:a systemic review of indirect evidence", 13, pp.4~15 (2000)
  4. "Herb-drug interactions: potentially important but woefully under-researched", 56, pp.523~524 (2000)
  5. "동서의학 진료 가이드북", pp.15~32 (2001), 고려의학
  6. "뇌졸중 환자의 한약양약 복합투여에 관한 단면연구", 27(1), pp.1~10 (2006)
  7. "뇌경색 환자의 warfarin(coumadin, warfar) 복용시 한약물이 INR에 미치는 영향", 25(2), pp.165~172 (2004)
  8. "Systematic overview of warfarin and its drug and food interactions", 165(10), pp.1095~1106 (2005)
  9. "Herbal remedies^anticoagulant therapy", 93(1), pp.3~7 (2005)
  10. "Drug interactions update: drugs, herbs, and oral anticoagulation", 12(1), pp.67~71 (2001)
  11. "Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence", 34, pp.1478~1482 (2000)
  12. "Herbal medicines and perioperative care", 286, pp.208~216 (2001)
  13. "Probable interactions between warfarin and ginseng", 54, pp.692~693 (1997)
  14. "Panax ginseng: a systematic review of adverse effects and drug interactions", 25(5), pp.323~344 (2002)
  15. "Potentiation of wafarin by dong quai", 19, pp.870~876 (1999)
  16. "Interaction between warfarin and danshen(Salvia miltiorrhiza)", 35, pp.501~503 (2001)
  17. "Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study", 32(12), pp.2735~2740 (2001)
  18. "American Heart Association", American College of Cardiology Foundation guide to warfarin therapy, 2003, pp.107, 1692~1711
  19. "Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers", 54, pp.1195~1203 (1997)
  20. "Interactions of herbs with cytochrome P450", 35, pp.35~98 (2003)
  21. "Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity", 71, pp.1579~1589 (2002)
  22. "Interaction of warfarin with drugs, natural substances, and foods", 45(2), pp.127~132 (2005)
  23. "Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach", 46(11), pp.1370~1378 (2006)
  24. "Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats", 51, pp.175~ (1999)
  25. "Effect of coenzyme Q10 and ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients: a randomised, double blind, placebo -crossover trial", 87, pp.1075~1076 (2002)
  26. "The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen", 106(7), pp.2329~2333 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (23건)